Bender Robert & Associates Exelixis, Inc. Transaction History

Bender Robert & Associates

$471 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$15.84 - $21.88 $926,148 - $1.28 Million	-58,469 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$16.3 - $21.14 $910,240 - $1.18 Million	55,843 Added 2126.54%	58,469 $1.24 Million
Q3 2021 Nov 03, 2021	SELL	$16.3 - $21.14 $1.15 Million - $1.49 Million	-70,589 Reduced 96.41%	2,626 $256,000
Q2 2021 Jul 16, 2021	SELL	$17.95 - $25.56 $170,794 - $243,203	-9,515 Reduced 11.5%	73,215 $1.33 Million
Q1 2021 Apr 28, 2021	SELL	$20.53 - $25.22 $57,791 - $70,994	-2,815 Reduced 3.29%	82,730 $1.87 Million
Q4 2020 Jan 29, 2021	SELL	$18.39 - $24.8 $37,607 - $50,716	-2,045 Reduced 2.33%	85,545 $1.72 Million
Q3 2020 Oct 29, 2020	SELL	$20.67 - $26.94 $53,328 - $69,505	-2,580 Reduced 2.86%	87,590 $2.14 Million
Q2 2020 Jul 31, 2020	BUY	$16.46 - $27.42 $39,668 - $66,082	2,410 Added 2.75%	90,170 $2.14 Million
Q1 2020 Apr 21, 2020	BUY	$14.46 - $21.8 $2,892 - $4,360	200 Added 0.23%	87,760 $1.51 Million
Q4 2019 Jan 31, 2020	SELL	$15.15 - $18.89 $94,005 - $117,212	-6,205 Reduced 6.62%	87,560 $1.54 Million
Q3 2019 Oct 15, 2019	SELL	$17.68 - $22.65 $36,155 - $46,319	-2,045 Reduced 2.13%	93,765 $1.66 Million
Q2 2019 Jul 30, 2019	SELL	$18.93 - $24.75 $66,538 - $86,996	-3,515 Reduced 3.54%	95,810 $1.99 Million
Q1 2019 Apr 30, 2019	BUY	$19.6 - $24.76 $85,848 - $108,448	4,380 Added 4.61%	99,325 $2.36 Million
Q4 2018 Jan 24, 2019	SELL	$13.65 - $21.8 $305,009 - $487,121	-22,345 Reduced 19.05%	94,945 $1.87 Million
Q3 2018 Oct 17, 2018	BUY	$15.87 - $22.4 $2,697 - $3,807	170 Added 0.15%	117,290 $2.08 Million
Q2 2018 Jul 27, 2018	BUY	$18.56 - $22.45 $481,724 - $582,689	25,955 Added 28.47%	117,120 $2.52 Million
Q1 2018 Apr 27, 2018	BUY	$22.15 - $31.89 $2.02 Million - $2.91 Million	91,165 New	91,165 $2.02 Million

Others Institutions Holding EXEL

# of Institutions

466

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.17 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.7M
Shares

$1.03 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

27.1M
Shares

$943 Million
2.95% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.2M
Shares

$527 Million
0.6% of portfolio
State Street Corp Boston, MA

12.6M
Shares

$438 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account